Raven biosciences ApS: Financial statements 2024
CVR: 39085127
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Raven biosciences ApS (CVR 39085127) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 5,095,382 and a net result of DKK -925,200 compared with DKK 429,534 the year before. That is a decrease of 27.8% compared with the year before. The profit margin was -18.2%. Equity in the 2024 report amounted to DKK 1,796,749. The solvency ratio was 34%. The company had 9 employees in the financial year.
- Revenue
- DKK 5,095,382
- Gross Profit
- DKK 4,114,838
- Profit/Loss
- DKK -925,200
- Equity
- DKK 1,796,749
- Total Assets
- DKK 5,278,142
- Employees
- 9
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 5.1M | 4.1M | -925K | 1.8M | 9 |
| 2023 | 7.1M | 6M | 430K | 3.9M | 7 |
| 2022 | 12.7M | 7.5M | 2.5M | 3.5M | 4 |
| 2021 | 6M | 3.4M | 710K | 1M | - |
| 2020 | 2.2M | 2.1M | -255K | 413K | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Raven biosciences ApS has published its annual report for 2023. Revenue came to DKK 7,055,096, and the net result was DKK 429,534.
About Raven biosciences ApS
Raven biosciences ApS is a Danish company of the type Anpartsselskab based in Aarhus N, founded in 2017. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The management consists of Kenneth Graabek Johansen and Roald Forsberg. The company's owners include Kenneth Graabek Johansen, Roald Forsberg and KGJ Invest ApS. The company has 7 employees (2026). In 2025, the company reported revenue of DKK 6,977,057 and a net result of DKK 1,065,066 compared with DKK -925,200 the year before. Equity in the 2025 report amounted to DKK 2,861,815.